bioMérieux S.A. (BMXXY)
OTCMKTS · Delayed Price · Currency is USD
13.83
+0.88 (6.80%)
At close: Jul 11, 2025
bioMérieux Employees
As of December 31, 2024, bioMérieux had 14,754 total employees, including 14,147 full-time and 607 part-time employees. The number of employees increased by 772 or 5.52% compared to the previous year.
Employees
14,754
Change (1Y)
772
Growth (1Y)
5.52%
Revenue / Employee
$285,129
Profits / Employee
$30,964
Market Cap
16.90B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14,754 | 772 | 5.52% |
Dec 31, 2023 | 13,982 | 847 | 6.45% |
Dec 31, 2022 | 13,135 | 756 | 6.11% |
Dec 31, 2021 | 12,379 | -245 | -1.94% |
Dec 31, 2020 | 12,624 | 624 | 5.20% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
American Oncology Network | 1,914 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
Silence Therapeutics | 116 |